Takeda recently announced that India’s Drug Controller General of India (DCGI) has granted marketing authorization for Takeda’s dengue vaccine (TAK-003) for the prevention of dengue disease in ...
India approves its first dengue vaccine, QDENGA, for people aged 4 to 60, marking a major step in preventing dengue ...
Climate change is helping invasive species to not only establish themselves across the continent but to stay alive for longer ...
What were the most important current affairs for UPSC this week? From India's 45th UNESCO World Heritage site and Ahimsa ...
India approves QDENGA, its first dengue vaccine. This milestone is only the start of a larger public health challenge.
“This work challenges existing assumptions about how dengue interacts with the immune system,” said Diehl. “By revealing a ...
Can one vaccine protect against all four dengue virus strains? How do countries prevent tax treaty abuse? And why are ...
Every rainy season and after it, Dengue (a serious viral disease spread by infected mosquitoes) wreaks havoc with the lives ...
Dengue infections reported across the United States jumped above the 2010 to 2023 baseline in 2024, driven by a combination ...
Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about ...
India approved its first dengue vaccine, Takeda's QDENGA, for ages 4–60. The two-dose vaccine protects against all four ...
A Timely Step Against a Seasonal Threat With the arrival of the monsoon, dengue cases surge across India, affecting countless ...